Newsroom
Featured News
Image
Innovation at Work
Advances in science and treatment are changing how severe hypertriglyceridemia (sHTG) is identified and managed. Here are four trends helping shape the future of care.
People & Impact
Ionis has been recognized as one of the San Diego Business Journal's Best Places to Work for the third consecutive year. This year, Ionis ranked #3 in the Large Company category, climbing three spots from #6 in 2025.
Image
Patient Voices
Explore Yajaira's journey with severe hypertriglyceridemia (sHTG), including the risks of high triglycerides, pancreatitis, and the importance of early awareness.
Image
People & Impact
Explore Ionis' 2025 Corporate Responsibility Report — covering RNA-targeted medicine breakthroughs, ESG commitments, employee impact, and sustainability milestones.
Image
Recent posts
Image
Innovation at Work
Four Trends That Will Shape the Future of Severe Hypertriglyceridemia (sHTG) Management
Image
People & Impact
Ionis recognized as a Top 3 Best Place to Work by San Diego Business Journal
Image
Patient Voices
Living with an Invisible Illness: Yajaira’s Journey with Severe Hypertriglyceridemia (sHTG)
Image
People & Impact
Our 2025 Corporate Responsibility Report: Building Momentum for Better Futures
Image
Patient Voices
From Treating ATTR-CM to Living with It: A Conversation with a Cardiologist
Image
Defining Moments
Ionis JPM 2026 Takeaways: Breakthrough Therapies Driving Accelerating Growth
Image
Patient Voices
Behind the Mystery of Angelman Syndrome: A Journey of Resilience and Strength
Image
Patient Voices
Meet Rick: Navigating Life with Familial Chylomicronemia Syndrome (FCS)
Image
Sign up for investor news alerts
For the latest on Ionis investor news.